Clinical trial
A Phase II Clinical Trial of Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
NCT05952934 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Clinical Trial of Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
- Lead sponsor
- University of Arkansas
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- February 12, 2024
- Completion date
- July 31, 2032
- Enrollment
- 100 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.